Skip to main content
Premium Trial:

Request an Annual Quote

BG Medicine's Q2 Revenues Plunge 47 Percent

NEW YORK (GenomeWeb News) – BG Medicine today said that second-quarter revenues dropped 47 percent year over year due to decreased activity in a project begun a few years ago to develop diagnostic biomarkers for heart attacks.

For the three months ended June 30, revenues dropped to $221,000 from $418,000 a year ago. In a statement, the company attributed the fall-off to lower activity in its High Risk Plaque Initiative aimed at developing biomarkers for predicting heart attacks caused by myocardial infarction or by the rupture of atherosclerotic plaque. The Waltham, Mass.-based firm also cited the absence of other service agreements for the reduction in revenue.

BG's R&D expenses increased 60 percent from $1.5 million to $2.4 million year over year due to an uptick in activity and personnel-related costs related to BG Medicine's internal biomarker discovery development work. Its SG&A costs rose 25 percent to $2.5 million from $2 million on medical education programs associated with the company's galectin-3 product and the costs of being a public company.

The firm went public in February.

BG's net loss for the quarter climbed 30 percent to $4.8 million, or $.25 per share, from $3.7 million, or $1.36 a share, a year ago. The company used 19.2 million shares to calculate its net loss per share in the quarter, compared to 2.9 million shares a year ago when it was privately held.

The firm ended the quarter with $19.1 million in cash, cash equivalents, and restricted cash, and $12.9 million in marketable securities.

BG noted that at least one of its partners is on track to submit an automated version of its Galectin-3 test to the US Food and Drug Administration by the end of 2011.

In morning trading on Nasdaq, shares of BG Medicine were up about 7 percent at $7.16.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.